Literature DB >> 20881175

Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.

Jussara K Palmeiro1, Libera M Dalla-Costa, Sérgio E L Fracalanzza, Ana C N Botelho, Keite da Silva Nogueira, Mara C Scheffer, Rosângela S L de Almeida Torres, Newton Sérgio de Carvalho, Laura Lúcia Cogo, Humberto M F Madeira.   

Abstract

One-hundred sixty-eight group B streptococcal (GBS) isolates from a Brazilian hospital were phenotypically and genotypically characterized. Isolates were recovered from human sources from April 2006 to May 2008 and classified as either invasive, noninvasive, or colonizing isolates. Classical methods for serotyping and antibiotic resistance profiling were employed. Clonal groups were also defined by pulsed-field gel electrophoresis (PFGE). Results showed that susceptibility to beta-lactam antimicrobials was predominant among the isolates. Only 4.7% were resistant to erythromycin and clindamycin. The erm(B) gene was widely detected in our GBS isolates, according to our phenotypic results (constitutive macrolide-lincosamide-streptogramin B [cMLSB] resistance phenotype), and the erm(A) gene was also detected in some isolates. MLSB resistance was restricted to strains isolated from patients with noninvasive infections and carriers. Serotype Ia was predominant (38.1%), serotype IV isolates were found at a high frequency (13.1%), and few isolates of serotype III were identified (3%). Pulsed-field gel electrophoresis results revealed a variety of types, reflecting the substantial genetic diversity among GBS strains, although a great number of isolates could be clustered into two major groups with a high degree of genetic relatedness. Three main PFGE clonal groups were found, and isolates sharing the same PFGE type were grouped into different serotypes. Furthermore, in a few cases, isolates from the same patients and possessing the same PFGE type were of different serotypes. These findings could be related to the occurrence of capsular switching by horizontal transfer of capsular genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881175      PMCID: PMC3008495          DOI: 10.1128/JCM.00419-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  53 in total

1.  False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.

Authors:  H-C Slotved; S Sauer; H B Konradsen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 3.  Genetic elements responsible for erythromycin resistance in streptococci.

Authors:  Pietro E Varaldo; Maria Pia Montanari; Eleonora Giovanetti
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

4.  Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea.

Authors:  K Lee; J W Shin; Y Chong; H Mikamo
Journal:  J Infect Chemother       Date:  2000-06       Impact factor: 2.211

5.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study.

Authors:  Sandra J Bliss; Shannon D Manning; Patricia Tallman; Carol J Baker; Mark D Pearlman; Carl F Marrs; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2001-12-05       Impact factor: 9.079

7.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Authors:  J I Andrews; D J Diekema; S K Hunter; P R Rhomberg; M A Pfaller; R N Jones; G V Doern
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

9.  Conjugate vaccines against group B Streptococcus types IV and VII.

Authors:  Lawrence C Paoletti; Dennis L Kasper
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

10.  Streptococcus agalactiae pulsed-field gel electrophoresis patterns cross capsular types.

Authors:  P Pillai; U Srinivasan; L Zhang; S M Borchardt; J Debusscher; C F Marrs; B Foxman
Journal:  Epidemiol Infect       Date:  2009-03-04       Impact factor: 2.451

View more
  22 in total

1.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.

Authors:  Sarah Teatero; Taryn B T Athey; Paul Van Caeseele; Greg Horsman; David C Alexander; Roberto G Melano; Aimin Li; Anthony R Flores; Samuel A Shelburne; Allison McGeer; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

Review 3.  Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.

Authors:  Cilicia S do Nascimento; Nayara F B Dos Santos; Rita C C Ferreira; Carla R Taddei
Journal:  Braz J Microbiol       Date:  2019-08-20       Impact factor: 2.476

4.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

5.  Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver Nanoparticles.

Authors:  Renata Perugini Biasi-Garbin; Eliane Saori Otaguiri; Alexandre Tadachi Morey; Mayara Fernandes da Silva; Ana Elisa Belotto Morguette; César Armando Contreras Lancheros; Danielle Kian; Márcia Regina Eches Perugini; Gerson Nakazato; Nelson Durán; Celso Vataru Nakamura; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-07       Impact factor: 2.629

6.  Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants.

Authors:  Eliane Saori Otaguiri; Ana Elisa Belotto Morguette; Eliandro Reis Tavares; Pollyanna Myrella Capela dos Santos; Alexandre Tadachi Morey; Juscélio Donizete Cardoso; Márcia Regina Eches Perugini; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  BMC Microbiol       Date:  2013-12-21       Impact factor: 3.605

7.  Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada.

Authors:  Sarah Teatero; Allison McGeer; Aimin Li; Janice Gomes; Christine Seah; Walter Demczuk; Irene Martin; Jessica Wasserscheid; Ken Dewar; Roberto G Melano; Nahuel Fittipaldi
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

8.  Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil.

Authors:  Glenda de Figueiredo Sanches; Pamella Silva Lannes-Costa; Melissa Coimbra Cristoforêto; Kelly S Doran; Ana Luíza Mattos-Guaraldi; Prescilla Emy Nagao
Journal:  Braz J Microbiol       Date:  2021-01-04       Impact factor: 2.476

9.  Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.

Authors:  Vanusa G Dutra; Valéria M N Alves; André N Olendzki; Cicero A G Dias; Alessandra F A de Bastos; Gianni O Santos; Efigênia L T de Amorin; Meireille  B Sousa; Rosemary Santos; Patricia C S Ribeiro; Cleuber F Fontes; Marco Andrey; Kedma Magalhães; Ana A Araujo; Lilian F Paffadore; Camila Marconi; Eddie F C Murta; Paulo C Fernandes; Maria S G Raddi; Penélope S Marinho; Rita B G Bornia; Jussara K Palmeiro; Libera M Dalla-Costa; Tatiana C A Pinto; Ana Caroline N Botelho; Lúcia M Teixeira; Sérgio Eduardo L Fracalanzza
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

Review 10.  Prevalence of Group B Streptococcus in Vagina and Rectum of Pregnant Women of Islamic & Non-Islamic Countries: A Systematic Review and Meta-Analysis.

Authors:  Fatemeh Abbasalizadeh; Sajjad Pourasghary; Maryam Shirizadeh; Sanaz Mousavi; Morteza Ghojazadeh; Hossein Hoseinifard; Fatemeh Salehnia; Leila Nikniaz
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.